FINWIRES · TerminalLIVE
FINWIRES

研究快訊:CC公司第一季業績喜憂參半,重點在於成長、獲利能力和債務削減。

By

-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:科慕公司第一季業績喜憂參半,銷售額為13.81億美元(年成長1%),低於預期2,000萬美元;調整後每股收益為0.05美元,超出預期0.09美元,但低於去年同期的0.13美元。由於融資成本上升及銷售、管理及行政費用增加,淨虧損從500萬美元擴大至2,900萬美元。業績反映出各業務板塊的顯著差異,TSS業務表現創歷史新高(年增22%至5.68億美元),抵銷了TT業務的疲軟(年減6%)和APM業務中斷(年減17%)的影響。管理層預計第二季銷售額將季增15%-20%,2026年全年年增3%-5%,調整後EBITDA為8億至9億美元。鑑於Opteon冷媒的廣泛應用以及汽車用氟利昂銷售強勁,我們對TSS的業績持樂觀態度,其調整後EBITDA利潤率達到33%。然而,我們仍擔憂TT的利潤率可能因亞洲低成本生產商的競爭壓力而壓縮至3%,以及APM因華盛頓工廠停產而面臨的營運挑戰。我們認為,在2026年底將淨槓桿率從4.9倍降至3.8倍以下的去槓桿化目標至關重要。

Related Articles

Asia

Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%

Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.

$ASX:AVR
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP